bimagrumab tirzepatide Lilly initiates Bimagrumab+Tirzepatide trial; Lexicon and Viatris Partner for Sotagliflozin Commercialization; Gan & Lee T2DM Assets Meet Primary Endpoints; Lipocine Virtual KOL Event; Noom Adds Body Composition to App F.D.A. Approves New Obesity Drug

Description

GLP-1 Weight & Wellness Program PROGRAM OVERVIEW: The GLP-1 Weight & Wellness Program is designed to help individuals achieve safe and sustainable weight loss while improving overall health outcomes

LEARN MORE ABOUT YOUR HEALTH IN OUR NEWSLETTER How Do You Know if Fibroids Are Breaking Down

In addition, the high cost of GLP-1 therapies remains a barrier, especially in markets with limited insurance coverage or constrained healthcare budgets The annual cost of treatment with drugs such as Wegovy or Zepbound can exceed several thousand dollars, which may limit accessibility for patients without comprehensive health coverage